GLP-1 receptor agonists beyond glycemic control: integrated cardio-renal-metabolic protection across the cardiovascular kidney metabolic continuum
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have undergone a fundamental repositioning, once defined by their glycemic effects, they are now established as multi-organ protective agents operating across the cardiovascular-kidney-metabolic (CKM) continuum with benefits that extend substantially beyond glucose l...